Delivery Order SPE2DB22D3301-SPE2DB23FZ0VT
Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $244
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $60,930 by the Defense Logistics Agency to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release for pharmaceutical use. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from July 7-10, 2023. The firm fixed price contract was awarded under the DLA's indefinite-delivery/indefinite-quantity...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $42,390 by the Defense Logistics Agency to provide 100 capsules of 25mg dextroamphetamine-amphetamine extended release for use by the Department of Defense. The single day contract has a period of performance from September 11-12, 2023 and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $12,810 by the Defense Logistics Agency to provide 100 capsules of 10mg dextroamphetamine-amphetamine extended release for use by the Department of Defense. The single day order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 27, 2023. No additional details were provided regarding the solicitation or any...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $12,810 by the Defense Logistics Agency to provide 100 capsules of 10mg dextroamphetamine-amphetamine extended release for use by the Department of Defense. The single day order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 12, 2023. No additional details were provided regarding the solicitation or...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $406,200 delivery order by the Defense Logistics Agency to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period concluding on September 8, 2023. The firm fixed price contract was issued under the DLA's indefinite-delivery/indefinite-quantity...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $60,750 delivery order by the Defense Logistics Agency to provide 100 capsules of 15mg dextroamphetamine-amphetamine extended release for pharmaceutical use. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by July 25, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $598 under the Defense Logistics Agency's pharmaceutical products indefinite-delivery/indefinite-quantity contract. The order is to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release to be delivered to a facility in Conshohocken, Pennsylvania by August 25, 2023. Funding is provided by the Defense Logistics Agency to support the...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $62,460 firm fixed price delivery order by the Defense Logistics Agency to supply 100 capsules of 20mg dextroamphetamine-amphetamine extended release medication. The single day contract issued on July 26, 2023 has a period of performance through July 27, 2023. To be performed in Conshohocken, Pennsylvania, this order is likely placed under DLA's Pharmaceutical Prime Vendor contract to support...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $28,260 by the Defense Logistics Agency to provide 100 capsules of 25mg dextroamphetamine-amphetamine extended release capsules. The single day contract has a period of performance from September 11-12, 2023 and will be performed in Conshohocken, Pennsylvania. No additional details were provided regarding the solicitation or vehicle against which this...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $81,000 by the Defense Logistics Agency to provide 100 capsules of 10mg dextroamphetamine-amphetamine extended release for performance on August 1-2, 2023. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. This order is likely in support of the...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ0VTDelivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $243.72 by the Defense Logistics Agency to provide 100 capsules of 20mg dextroamphetamine-amphetamine extended release for performance from July 7-10, 2023. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order issued against the DLA's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract to supply various pharmaceutical products and services to DOD components worldwide. No subcontractors or set aside designations were indicated.
Generated 12/23/23, 12:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $244 | 7/7/23 |